Globalepolicy.org is a free to access global medical news service for the consumer, professional and researcher.
Background: A treatment algorithm and screening examination have been developed to guide patient management and prospectively determine potential for highly active individuals to succeed with nonoperative care after anterior cruciate ligament rupture.
Objective: To prospectively characterize and classify the entire population of highly active individuals over a 10-year period and provide final outcomes for individuals who elected nonoperative care.
Methods: Inclusion criteria included presentation within 7 months of the index injury and an International Knee Documentation Committee level I or II activity level before injury. Concomitant injury, unresolved impairments, and a screening examination were used as criteria to guide management and classify individuals as noncopers (poor potential) or potential copers (good potential) for nonoperative care.
Results: A total of 832 highly active patients with subacute anterior cruciate ligament tears were seen over the 10-year period; 315 had concomitant injuries, 87 had unresolved impairments, and 85 did not participate in the classification algorithm. The remaining 345 patients (216 men, 129 women) participated in the screening examination a mean of 6 weeks after the index injury. There were 199 subjects classified as noncopers and 146 as potential copers. Sixty-three of 88 potential copers successfully returned to preinjury activities without surgery, with 25 of these patients not undergoing anterior cruciate ligament reconstruction at the time of follow-up.
Conclusion: The classification algorithm is an effective tool for prospectively identifying individuals early after anterior cruciate ligament injury who want to pursue nonoperative care or must delay surgical intervention and have good potential to do so.
NAVIGATION
|
26
Aug |
U.S. Navy Reaches Agreement To Purchase QBC STAR Hematology Analyzers For Use On Its Surface FleetCategory: Blood / Hematology | Leave a Comment |
QBC Diagnostics was awarded one of the largest contracts in company history, as the United States Navy has agreed to install QBC STAR hematology analyzers on surface ships throughout the world. The QBC STAR provides users a 9-parameter complete blood count through its patented dry hematology approach, which eliminates the need for liquid reagents…
|
11
Aug |
FDA Clears Software Upgrade For Fenwal Plasma-Collection SystemCategory: Blood / Hematology | Leave a Comment |
Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced that the U.S. Food and Drug Administration has granted Fenwal 510(k) clearance to market a new software release for its Autopheresis-C® system. Blood and plasma centers worldwide use the Autopheresis-C system to collect plasma from donors…
|
7
Aug |
ICU Medical, Inc. Receives FDA Clearance For The Neutron™ Neutral-Pressure Needleless ConnectorCategory: Blood / Hematology | Leave a Comment |
ICU Medical, Inc. (Nasdaq: ICUI), a worldwide leader in the development, manufacture and sale of proprietary, disposable medical connection systems for use in vascular therapy applications, confirmed that it has received FDA 510-k clearance for the Neutron™ Neutral-Pressure Needleless Connector…
|
30
Jul |
AdvanDx Receives FDA 510(k) Clearance For 90 Minutes Protocol For Yeast Traffic Light® PNA FISH®Category: Blood / Hematology | Leave a Comment |
AdvanDx announced that it has received FDA 510(k) clearance for a fast, 90 minutes protocol for its Yeast Traffic Light® PNA FISH® test. The faster protocol reduces the PNA FISH turn-around time from the original 2.5 hours to 90 minutes by reducing PNA probe hybridization from 90 minutes to 30 minutes…
|
27
Jul |
Roche Receives FDA Clearance For CoaguChek XS Pro System With Bar Code Reader For PT/INR Testing At The Point Of CareCategory: Blood / Hematology | Leave a Comment |
Roche Diagnostics announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the CoaguChek® XS Pro system, a new point-of-care anticoagulation monitor with a built-in bar code reader that can automatically scan and capture operator and patient identification information…
|
3
Jun |
First Paper ‘Dipstick’ Test For Determining Blood TypeCategory: Blood / Hematology | Leave a Comment |
Scientists are reporting development of the first “dipstick” test for instantly determining a person’s blood type at a cost of just a few pennies. Their study on the test, which involves placing a drop of blood on a specially treated paper strip, appears in ACS’ semi-monthly journal Analytical Chemistry, where the authors say it could be a boon to health care in developing countries…
|
3
Jun |
CoaguSense Receives FDA Clearance For The CoaguSense Blood Coagulation Testing System For Patient Home UseCategory: Blood / Hematology | Leave a Comment |
CoaguSense™, Inc., a diagnostic device company that has been in stealth mode for the past two years, today unveiled the first portable point-of-care Prothrombin Time/International Normalized Ratio (PT/INR) analyzer to directly detect blood clotting time for patients stabilized on oral anti-coagulation medications such as Coumadin® or warfarin…
|
28
Apr |
EHSI To Add Blood Disorder Treatment Module To Medical IPhone AppCategory: Blood / Hematology | Leave a Comment |
Emerging Healthcare Solutions, Inc. (Pink Sheets:EHSI) announced that the Company is adding a module to incorporate at home diagnosis and monitoring of various blood disorders as options to its new breakthrough medical iPhone app, currently in development…
|
23
Apr |
New Promega Maxwell(R) 16 LEV Blood DNA Kit Surpasses Concentration Standards In Less TimeCategory: Blood / Hematology | Leave a Comment |
Promega Corporation now offers the Maxwell® 16 LEV Blood DNA Kit which is designed to purify DNA from whole blood. The new kit, optimized to work on the Maxwell® 16 instrument, eliminates the need for a buffy coat step while providing exponentially higher concentration in less time with parallel purity…
|
7
Apr |
Device To Change Preventive Blood Clot Care After Joint Replacement SurgeryCategory: Blood / Hematology | Leave a Comment |
A mobile compression device is as effective as medication at preventing the formation of blood clots after hip replacement surgery but provides greater patient safety, according to a study in the March issue of the Journal of Bone & Joint Surgery. “This device is as useful as blood thinners for the reduction of blood clots after hip replacement and it’s superior in safety,” said Douglas E…